共 50 条
- [1] TREATMENT OF POLYCYSTIC OVARY SYNDROME (PCO) WITH PURE FOLLICLE-STIMULATING-HORMONE (FSH) OR HUMAN MENOPAUSAL GONADOTROPINS (HMG) [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1988, 95 (05): : 534 - 534
- [3] COMPARISON BETWEEN HUMAN URINARY FOLLICLE-STIMULATING-HORMONE AND HUMAN MENOPAUSAL GONADOTROPIN TREATMENT IN POLYCYSTIC OVARY [J]. OBSTETRICS AND GYNECOLOGY, 1984, 63 (01): : 6 - 11
- [4] COAGULATION CHANGES FOLLOWING OVARIAN STIMULATION WITH HUMAN MENOPAUSAL GONADOTROPIN (HMG) AND HUMAN CHORIONIC GONADOTROPIN (HCG) [J]. OBSTETRICS AND GYNECOLOGY, 1967, 29 (03): : 432 - &
- [6] DELINEATION OF MECHANISM OF INAPPROPRIATE SECRETION OF LH AND FSH IN POLYCYSTIC OVARIAN DISEASE (PCO) [J]. GYNECOLOGIC INVESTIGATION, 1975, 6 (1-2): : 8 - 9
- [8] Does the Use of Highly Purified Human Menopausal Gonadotrophin (HP-HMG) Avoid Ovarian Hyperstimulation Syndrome (OHSS) in Polycystic Ovary (PCO) Patients in Assisted Reproduction (IVF/ICSI)? [J]. 18TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2014, : 77 - 83